The research study on the live cell imaging market – global outlook & forecast market 2022-2027, recently published by Arizton Advisory & Intelligence, states that the market will grow at a CAGR of 8.44% during 2021-2027.
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3472
The global live-cell imaging market growth is primarily driven by the increasing prevalence of cancer and infectious diseases, which require innovative therapies. Additionally, the demand for cell biology studies and the growing awareness of stem cell therapy contributes to live-cell imaging technologies’ adoption.
Researchers from pharmaceutical and biotech companies, academic institutions, and research centers heavily rely on fluorescence microscopy techniques, resulting in a high demand for live-cell imaging systems. Furthermore, integrating artificial intelligence (AI) and machine learning in live-cell imaging will drive the market’s growth in the coming years.
The global live-cell imaging market is segmented based on product, technique, application, end-user, and geography. In 2021, the equipment segment accounted for the largest share of the market. However, during the forecast period, the consumables segment is projected to witness the highest CAGR of 9.35%. This growth can be attributed to the continuous need for consumables such as reagents, probes, and assays in live-cell imaging experiments.
Overall, the expanding global live-cell imaging market signifies the importance of these technologies in various fields. With advancements in AI and machine learning and the rising demand for novel therapies and cell biology research, live-cell imaging is poised to play a crucial role in driving advancements in healthcare and life sciences.
Live Cell Imaging Market Report Scope
|Market Size (2027)||USD 3.54 Billion|
|Market Size (2021)||USD 2.18 Billion|
|Market Segmentation||Product Type, Technique Type, Application Type, End-User Type|
|Geographic Analysis||North America, Europe, APAC, Latin America, and Middle East & Africa|
Buy the Report Now: https://www.arizton.com/market-reports/live-cell-imaging-market
- 1hr of free analyst discussion
- 10% of customization
Recent Developments in the Global Market
- In 2021, CytoSMART launched CytoSMART Lux3 BR, a new type of bright-field microscope, i.e., a live-cell imaging microscope equipped with a high-quality CMOS camera to assist label-free cell imaging procedures.
- In 2021, the Zeiss group announced that they would launch Zeiss Visioner 1, a Zeiss live cell imaging system, an innovative digital microscope that facilitates real-time all-in-one focus via a micro-mirror array system.
- In 2020, CytoSMART Technologies launched CytoSMART Multi Lux, a remote live cell imaging system.
The global live cell imaging market is poised for substantial growth, with North America leading. This growth is primarily driven by increased healthcare spending and funding for research and development in live cell-driven drug discovery, development, and personalized medicine.
Europe holds the second-largest share in the global market, driven by a growing patient population requiring innovative treatments like stem cell therapy and gene therapy. Additionally, the region benefits from a surge in drug approvals for precision medicine, government funding for research-based activities, rapid advancements in live cell imaging, and several other contributing factors.
The Asia-Pacific (APAC) region is expected to witness the fastest growth in the global live cell imaging market. Key factors contributing to this growth include a continual rise in the prevalence of cancers and infectious diseases, increasing demand for stem cell research studies, rising research and development expenditures, the growing utility of biomarkers for diagnostic purposes, heightened awareness of cell and gene therapies, the need for precision medicine, and advancements in drug discovery, cell biology, and development.
On the other hand, Latin America and the Middle East & Africa regions currently hold minimal shares in the global market for live cell imaging.
The expansion of the live cell imaging market indicates the increasing importance of these systems in various sectors. They play a crucial role in diagnostics, drug discovery and development, and precision medicine. As research and technological advancements progress, live cell imaging systems are expected to become even more essential tools in healthcare and life sciences.
Market Trends & Opportunities
Deep Learning & Artificial Intelligence
The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently, AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.
Increase in Funding for Cell & Gene Therapy
The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers. Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.
Advancements & Newer Imaging Techniques
Live cell imaging arises from scientific interest and improvements in imaging and labeling technology. Combining various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.
Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.
- Agilent Technologies
- Merck KGaA
- Thermo Fisher Scientific
- Axion BioSystems
- Bio-Rad Laboratories
- Blue-Ray Biotech
- Grace Bio-Labs
- ibidi GmbH
- Intelligent Imaging Innovations
- Logos Biosystems
- Nanolive SA
- Oxford Instruments
- Phase Focus
- Phase Holographic Imaging PHI AB
- Proteintech Group
- Sartorius AG
- Sony Biotechnology
- Product: Equipment, Consumables, and Software
- Technique: Fluorescence microscopy, Confocal microscopy, Transmitted light microscopy, and Others
- Application: Cell Biology, Drug Discovery, Developmental Biology, and Stem Cells
- End-user: Pharma & Biotech Companies, Academic & research centers, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
To Get the Benefit of Our Free Report Customization Service, Send Your Enquiry Here – https://www.arizton.com/customize-report/3472
Why Arizton Research Reports?
100% Customer Satisfaction
24×7 availability – we are always there when you need us.
200+ Fortune 500 Companies trust Arizton’s report.
80% of our reports are exclusive and first in the industry.
100% more data and analysis.
1000+ reports published to date.
Arizton’s Expertise in the Healthcare Industry
Arizton offers syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provides unbiased research and evidence-based analysis to support business decisions and comprehensive end-to-end solutions to its customers, covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, and CMO/CDMO services.
Explore more healthcare reports: https://www.arizton.com/market-reports/category/healthcare-lifesciences
Check Out Some of the Top-Selling Research Reports:
Cell and Gene Therapy Market – Global Outlook & Forecast 2022-2027
3D Medical Imaging Market – Global Outlook & Forecast 2022-2027
AI In Medical Imaging Market – Global Outlook & Forecast 2022-2027
Mobile Medical Imaging Services Market – Global Outlook & Forecast 2022-2027
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.